APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nausea And Vomiting Treatment

Nausea and Vomiting Treatment also called Antiemetics. Antiemetics included aprepitant, diphenhydramine, granisetron, hydroxyzine, meclizine, ondansetron, prochlorperazine, promethazine, scopolamine, metoclopramide, trimethobenzamide, palonosetron, dolasetron, and thiethylperazine, etc.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Nausea and Vomiting Treatment also called Antiemetics. Antiemetics included aprepitant, diphenhydramine, granisetron, hydroxyzine, meclizine, ondansetron, prochlorperazine, promethazine, scopolamine, metoclopramide, trimethobenzamide, palonosetron, dolasetron, and thiethylperazine, etc.

Selected research

Industry Growth & Trends

Global Nausea And Vomiting Treatment Industry Growth and Trends Forecast to 2032

19 December 2025100 pages

Choose your research edition.

Industry ResearchNausea And Vomiting Treatment Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Nausea And Vomiting Treatment Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Nausea And Vomiting Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nausea And Vomiting Treatment Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Nausea And Vomiting Treatment Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Nausea and Vomiting Treatment also called Antiemetics. Antiemetics included aprepitant, diphenhydramine, granisetron, hydroxyzine, meclizine, ondansetron, prochlorperazine, promethazine, scopolamine, metoclopramide, trimethobenzamide, palonosetron, dolasetron, and thiethylperazine, etc.

According to APO Research, the global Nausea And Vomiting Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Nausea And Vomiting Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nausea And Vomiting Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nausea And Vomiting Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nausea And Vomiting Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Nausea And Vomiting Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nausea And Vomiting Treatment Market by Company

Merck & Co. Inc.

Helsinn Group

Unimed Pharmaceuticals (AbbVie Inc.)

Kyowa Kirin

Sanofi

Qilu Pharma

Teva Pharmaceutical Industries Ltd.

Taiji group

Novartis

Heron Therapeutics

Atnahs Pharma UK Limited

Mylan

Duchesnay

Tesaro

Nausea And Vomiting Treatment Segment by Type

Serotonin Receptor Antagonist

Neurokinin NK1 Receptor Antagonist

Others

Nausea And Vomiting Treatment Segment by Application

CINV

PONV

Motion Sickness

Pregnancy

Others

Nausea And Vomiting Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nausea And Vomiting Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nausea And Vomiting Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nausea And Vomiting Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Nausea And Vomiting Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Nausea And Vomiting Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Nausea And Vomiting Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Nausea And Vomiting Treatment Market Share by Region (2021-2026) Table 4. Global Nausea And Vomiting Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Nausea And Vomiting Treatment Market Share by Region (2027-2032) Table 6. Global Nausea And Vomiting Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Nausea And Vomiting Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Nausea And Vomiting Treatment Market Size Share by Type (2021-2026) Table 9. Global Nausea And Vomiting Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Nausea And Vomiting Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America Nausea And Vomiting Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Nausea And Vomiting Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Nausea And Vomiting Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Nausea And Vomiting Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Nausea And Vomiting Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Nausea And Vomiting Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Nausea And Vomiting Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Nausea And Vomiting Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Nausea And Vomiting Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Nausea And Vomiting Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Nausea And Vomiting Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Nausea And Vomiting Treatment Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Nausea And Vomiting Treatment Market Size Share by Application (2021-2026) Table 24. Global Nausea And Vomiting Treatment Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Nausea And Vomiting Treatment Market Size Share Forecasted by Application (2027-2032) Table 26. North America Nausea And Vomiting Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Nausea And Vomiting Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Nausea And Vomiting Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Nausea And Vomiting Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Nausea And Vomiting Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Nausea And Vomiting Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Nausea And Vomiting Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Nausea And Vomiting Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Nausea And Vomiting Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Nausea And Vomiting Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Nausea And Vomiting Treatment Industry Trends Table 37. Nausea And Vomiting Treatment Industry Drivers Table 38. Nausea And Vomiting Treatment Industry Opportunities and Challenges Table 39. Nausea And Vomiting Treatment Industry Restraints Table 40. Global Nausea And Vomiting Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Nausea And Vomiting Treatment Revenue Market Share by Company (2021-2026) Table 42. Global Nausea And Vomiting Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Nausea And Vomiting Treatment Key Company Headquarters & Area Served Table 44. Global Nausea And Vomiting Treatment Company, Product Type & Application Table 45. Global Nausea And Vomiting Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Nausea And Vomiting Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Merck & Co. Inc. Company Information Table 49. Merck & Co. Inc. Business Overview Table 50. Merck & Co. Inc. Nausea And Vomiting Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Merck & Co. Inc. Nausea And Vomiting Treatment Product Portfolio Table 52. Merck & Co. Inc. Recent Development Table 53. Helsinn Group Company Information Table 54. Helsinn Group Business Overview Table 55. Helsinn Group Nausea And Vomiting Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Helsinn Group Nausea And Vomiting Treatment Product Portfolio Table 57. Helsinn Group Recent Development Table 58. Unimed Pharmaceuticals (AbbVie Inc.) Company Information Table 59. Unimed Pharmaceuticals (AbbVie Inc.) Business Overview Table 60. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Product Portfolio Table 62. Unimed Pharmaceuticals (AbbVie Inc.) Recent Development Table 63. Kyowa Kirin Company Information Table 64. Kyowa Kirin Business Overview Table 65. Kyowa Kirin Nausea And Vomiting Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Kyowa Kirin Nausea And Vomiting Treatment Product Portfolio Table 67. Kyowa Kirin Recent Development Table 68. Sanofi Company Information Table 69. Sanofi Business Overview Table 70. Sanofi Nausea And Vomiting Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Sanofi Nausea And Vomiting Treatment Product Portfolio Table 72. Sanofi Recent Development Table 73. Qilu Pharma Company Information Table 74. Qilu Pharma Business Overview Table 75. Qilu Pharma Nausea And Vomiting Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Qilu Pharma Nausea And Vomiting Treatment Product Portfolio Table 77. Qilu Pharma Recent Development Table 78. Teva Pharmaceutical Industries Ltd. Company Information Table 79. Teva Pharmaceutical Industries Ltd. Business Overview Table 80. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Product Portfolio Table 82. Teva Pharmaceutical Industries Ltd. Recent Development Table 83. Taiji group Company Information Table 84. Taiji group Business Overview Table 85. Taiji group Nausea And Vomiting Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Taiji group Nausea And Vomiting Treatment Product Portfolio Table 87. Taiji group Recent Development Table 88. Novartis Company Information Table 89. Novartis Business Overview Table 90. Novartis Nausea And Vomiting Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Novartis Nausea And Vomiting Treatment Product Portfolio Table 92. Novartis Recent Development Table 93. Heron Therapeutics Company Information Table 94. Heron Therapeutics Business Overview Table 95. Heron Therapeutics Nausea And Vomiting Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Heron Therapeutics Nausea And Vomiting Treatment Product Portfolio Table 97. Heron Therapeutics Recent Development Table 98. Atnahs Pharma UK Limited Company Information Table 99. Atnahs Pharma UK Limited Business Overview Table 100. Atnahs Pharma UK Limited Nausea And Vomiting Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Atnahs Pharma UK Limited Nausea And Vomiting Treatment Product Portfolio Table 102. Atnahs Pharma UK Limited Recent Development Table 103. Mylan Company Information Table 104. Mylan Business Overview Table 105. Mylan Nausea And Vomiting Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Mylan Nausea And Vomiting Treatment Product Portfolio Table 107. Mylan Recent Development Table 108. Duchesnay Company Information Table 109. Duchesnay Business Overview Table 110. Duchesnay Nausea And Vomiting Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Duchesnay Nausea And Vomiting Treatment Product Portfolio Table 112. Duchesnay Recent Development Table 113. Tesaro Company Information Table 114. Tesaro Business Overview Table 115. Tesaro Nausea And Vomiting Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Tesaro Nausea And Vomiting Treatment Product Portfolio Table 117. Tesaro Recent Development Table 118. North America Nausea And Vomiting Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America Nausea And Vomiting Treatment Market Size by Country (2021-2026) & (US$ Million) Table 120. North America Nausea And Vomiting Treatment Market Share by Country (2021-2026) Table 121. North America Nausea And Vomiting Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America Nausea And Vomiting Treatment Market Share Forecast by Country (2027-2032) Table 123. Europe Nausea And Vomiting Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe Nausea And Vomiting Treatment Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe Nausea And Vomiting Treatment Market Share by Country (2021-2026) Table 126. Europe Nausea And Vomiting Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe Nausea And Vomiting Treatment Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Nausea And Vomiting Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Nausea And Vomiting Treatment Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific Nausea And Vomiting Treatment Market Share by Country (2021-2026) Table 131. Asia-Pacific Nausea And Vomiting Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific Nausea And Vomiting Treatment Market Share Forecast by Country (2027-2032) Table 133. Latin America Nausea And Vomiting Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Nausea And Vomiting Treatment Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Nausea And Vomiting Treatment Market Share by Country (2021-2026) Table 136. Latin America Nausea And Vomiting Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Nausea And Vomiting Treatment Market Share Forecast by Country (2027-2032) Table 138. Middle East & Africa Nausea And Vomiting Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2021-2026) & (US$ Million) Table 140. Middle East & Africa Nausea And Vomiting Treatment Market Share by Country (2021-2026) Table 141. Middle East & Africa Nausea And Vomiting Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Middle East & Africa Nausea And Vomiting Treatment Market Share Forecast by Country (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Nausea And Vomiting Treatment Product Image Figure 3. Global Nausea And Vomiting Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Nausea And Vomiting Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global Nausea And Vomiting Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global Nausea And Vomiting Treatment Market Share by Region (2021-2032) Figure 7. North America Nausea And Vomiting Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Nausea And Vomiting Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Nausea And Vomiting Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Nausea And Vomiting Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Nausea And Vomiting Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Serotonin Receptor Antagonist Image Figure 13. Global Serotonin Receptor Antagonist Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Neurokinin NK1 Receptor Antagonist Image Figure 15. Global Neurokinin NK1 Receptor Antagonist Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Others Image Figure 17. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Nausea And Vomiting Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Nausea And Vomiting Treatment Market Share by Type 2025 VS 2032 Figure 20. North America Nausea And Vomiting Treatment Market Size Share by Type (2021-2032) Figure 21. Europe Nausea And Vomiting Treatment Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Nausea And Vomiting Treatment Market Size Share by Type (2021-2032) Figure 23. Latin America Nausea And Vomiting Treatment Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Nausea And Vomiting Treatment Market Size Share by Type (2021-2032) Figure 25. CINV Image Figure 26. Global CINV Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. PONV Image Figure 28. Global PONV Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Motion Sickness Image Figure 30. Global Motion Sickness Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Pregnancy Image Figure 32. Global Pregnancy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Others Image Figure 34. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Nausea And Vomiting Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Nausea And Vomiting Treatment Market Share by Application 2025 VS 2032 Figure 37. North America Nausea And Vomiting Treatment Market Size Share by Application (2021-2032) Figure 38. Europe Nausea And Vomiting Treatment Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Nausea And Vomiting Treatment Market Size Share by Application (2021-2032) Figure 40. Latin America Nausea And Vomiting Treatment Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Nausea And Vomiting Treatment Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Nausea And Vomiting Treatment Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Nausea And Vomiting Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Nausea And Vomiting Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Nausea And Vomiting Treatment Market Share by Country (2021-2032) Figure 47. Europe Nausea And Vomiting Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Nausea And Vomiting Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Nausea And Vomiting Treatment Market Share by Country (2021-2032) Figure 50. Asia-Pacific Nausea And Vomiting Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Nausea And Vomiting Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Nausea And Vomiting Treatment Market Share by Country (2021-2032) Figure 53. Latin America Nausea And Vomiting Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Nausea And Vomiting Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Nausea And Vomiting Treatment Market Share by Country (2021-2032) Figure 56. Middle East & Africa Nausea And Vomiting Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Nausea And Vomiting Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Nausea And Vomiting Treatment Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Serotonin Receptor Antagonist
  • Neurokinin NK1 Receptor Antagonist
  • Others
Applications
  • CINV
  • PONV
  • Motion Sickness
  • Pregnancy
  • Others
Companies covered
  • Merck & Co. Inc.
  • Helsinn Group
  • Unimed Pharmaceuticals (AbbVie Inc.)
  • Kyowa Kirin
  • Sanofi
  • Qilu Pharma
  • Teva Pharmaceutical Industries Ltd.
  • Taiji group
  • Novartis
  • Heron Therapeutics
  • Atnahs Pharma UK Limited
  • Mylan
  • Duchesnay
  • Tesaro

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Nausea And Vomiting Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Nausea And Vomiting Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global Nausea And Vomiting Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global Nausea And Vomiting Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions Nausea And Vomiting Treatment Market Size (2021-2032)
  8. 1.5.1 North America Nausea And Vomiting Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Nausea And Vomiting Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Nausea And Vomiting Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Nausea And Vomiting Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Nausea And Vomiting Treatment Market Size Growth Rate (2021-2032)
2 Nausea And Vomiting Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Serotonin Receptor Antagonist
  3. 2.1.2 Neurokinin NK1 Receptor Antagonist
  4. 2.1.3 Others
  5. 2.2 Global Nausea And Vomiting Treatment Market Size by Type
  6. 2.2.1 Global Nausea And Vomiting Treatment Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Nausea And Vomiting Treatment Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Nausea And Vomiting Treatment Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Nausea And Vomiting Treatment Market Size by Regions
  10. 2.3.1 North America Nausea And Vomiting Treatment Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Nausea And Vomiting Treatment Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Nausea And Vomiting Treatment Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Nausea And Vomiting Treatment Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Nausea And Vomiting Treatment Market Size Breakdown by Type (2021-2026)
3 Nausea And Vomiting Treatment Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 CINV
  3. 3.1.2 PONV
  4. 3.1.3 Motion Sickness
  5. 3.1.4 Pregnancy
  6. 3.1.5 Others
  7. 3.2 Global Nausea And Vomiting Treatment Market Size by Application
  8. 3.2.1 Global Nausea And Vomiting Treatment Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Nausea And Vomiting Treatment Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Nausea And Vomiting Treatment Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Nausea And Vomiting Treatment Market Size by Regions
  12. 3.3.1 North America Nausea And Vomiting Treatment Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Nausea And Vomiting Treatment Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Nausea And Vomiting Treatment Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Nausea And Vomiting Treatment Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Nausea And Vomiting Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Nausea And Vomiting Treatment Industry Trends
  2. 4.2 Nausea And Vomiting Treatment Industry Drivers
  3. 4.3 Nausea And Vomiting Treatment Industry Opportunities and Challenges
  4. 4.4 Nausea And Vomiting Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Nausea And Vomiting Treatment Revenue (2021-2026)
  2. 5.2 Global Nausea And Vomiting Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Nausea And Vomiting Treatment Key Company Headquarters & Area Served
  4. 5.4 Global Nausea And Vomiting Treatment Company, Product Type & Application
  5. 5.5 Global Nausea And Vomiting Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Nausea And Vomiting Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Nausea And Vomiting Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Nausea And Vomiting Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Merck & Co. Inc.
  2. 6.1.1 Merck & Co. Inc. Company Information
  3. 6.1.2 Merck & Co. Inc. Business Overview
  4. 6.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Merck & Co. Inc. Nausea And Vomiting Treatment Product Portfolio
  6. 6.1.5 Merck & Co. Inc. Recent Developments
  7. 6.2 Helsinn Group
  8. 6.2.1 Helsinn Group Company Information
  9. 6.2.2 Helsinn Group Business Overview
  10. 6.2.3 Helsinn Group Nausea And Vomiting Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Helsinn Group Nausea And Vomiting Treatment Product Portfolio
  12. 6.2.5 Helsinn Group Recent Developments
  13. 6.3 Unimed Pharmaceuticals (AbbVie Inc.)
  14. 6.3.1 Unimed Pharmaceuticals (AbbVie Inc.) Company Information
  15. 6.3.2 Unimed Pharmaceuticals (AbbVie Inc.) Business Overview
  16. 6.3.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Product Portfolio
  18. 6.3.5 Unimed Pharmaceuticals (AbbVie Inc.) Recent Developments
  19. 6.4 Kyowa Kirin
  20. 6.4.1 Kyowa Kirin Company Information
  21. 6.4.2 Kyowa Kirin Business Overview
  22. 6.4.3 Kyowa Kirin Nausea And Vomiting Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Kyowa Kirin Nausea And Vomiting Treatment Product Portfolio
  24. 6.4.5 Kyowa Kirin Recent Developments
  25. 6.5 Sanofi
  26. 6.5.1 Sanofi Company Information
  27. 6.5.2 Sanofi Business Overview
  28. 6.5.3 Sanofi Nausea And Vomiting Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Sanofi Nausea And Vomiting Treatment Product Portfolio
  30. 6.5.5 Sanofi Recent Developments
  31. 6.6 Qilu Pharma
  32. 6.6.1 Qilu Pharma Company Information
  33. 6.6.2 Qilu Pharma Business Overview
  34. 6.6.3 Qilu Pharma Nausea And Vomiting Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Qilu Pharma Nausea And Vomiting Treatment Product Portfolio
  36. 6.6.5 Qilu Pharma Recent Developments
  37. 6.7 Teva Pharmaceutical Industries Ltd.
  38. 6.7.1 Teva Pharmaceutical Industries Ltd. Company Information
  39. 6.7.2 Teva Pharmaceutical Industries Ltd. Business Overview
  40. 6.7.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Product Portfolio
  42. 6.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  43. 6.8 Taiji group
  44. 6.8.1 Taiji group Company Information
  45. 6.8.2 Taiji group Business Overview
  46. 6.8.3 Taiji group Nausea And Vomiting Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Taiji group Nausea And Vomiting Treatment Product Portfolio
  48. 6.8.5 Taiji group Recent Developments
  49. 6.9 Novartis
  50. 6.9.1 Novartis Company Information
  51. 6.9.2 Novartis Business Overview
  52. 6.9.3 Novartis Nausea And Vomiting Treatment Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Novartis Nausea And Vomiting Treatment Product Portfolio
  54. 6.9.5 Novartis Recent Developments
  55. 6.10 Heron Therapeutics
  56. 6.10.1 Heron Therapeutics Company Information
  57. 6.10.2 Heron Therapeutics Business Overview
  58. 6.10.3 Heron Therapeutics Nausea And Vomiting Treatment Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Heron Therapeutics Nausea And Vomiting Treatment Product Portfolio
  60. 6.10.5 Heron Therapeutics Recent Developments
  61. 6.11 Atnahs Pharma UK Limited
  62. 6.11.1 Atnahs Pharma UK Limited Company Information
  63. 6.11.2 Atnahs Pharma UK Limited Business Overview
  64. 6.11.3 Atnahs Pharma UK Limited Nausea And Vomiting Treatment Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Atnahs Pharma UK Limited Nausea And Vomiting Treatment Product Portfolio
  66. 6.11.5 Atnahs Pharma UK Limited Recent Developments
  67. 6.12 Mylan
  68. 6.12.1 Mylan Company Information
  69. 6.12.2 Mylan Business Overview
  70. 6.12.3 Mylan Nausea And Vomiting Treatment Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Mylan Nausea And Vomiting Treatment Product Portfolio
  72. 6.12.5 Mylan Recent Developments
  73. 6.13 Duchesnay
  74. 6.13.1 Duchesnay Company Information
  75. 6.13.2 Duchesnay Business Overview
  76. 6.13.3 Duchesnay Nausea And Vomiting Treatment Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Duchesnay Nausea And Vomiting Treatment Product Portfolio
  78. 6.13.5 Duchesnay Recent Developments
  79. 6.14 Tesaro
  80. 6.14.1 Tesaro Company Information
  81. 6.14.2 Tesaro Business Overview
  82. 6.14.3 Tesaro Nausea And Vomiting Treatment Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Tesaro Nausea And Vomiting Treatment Product Portfolio
  84. 6.14.5 Tesaro Recent Developments
7 North America
  1. 7.1 North America Nausea And Vomiting Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Nausea And Vomiting Treatment Market Size by Country (2021-2026)
  3. 7.3 North America Nausea And Vomiting Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Nausea And Vomiting Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Nausea And Vomiting Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe Nausea And Vomiting Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Nausea And Vomiting Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Nausea And Vomiting Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Nausea And Vomiting Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Nausea And Vomiting Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Nausea And Vomiting Treatment Market Size by Country (2021-2026)
  3. 10.3 South America Nausea And Vomiting Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Nausea And Vomiting Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Nausea And Vomiting Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst